Bliss GVS Pharma Limited has informed the Exchange about Copy of Newspaper Publication regarding Publication of Notice to Shareholders for Transfer of Unclaimed Final Dividend 2017-2018 and its corresponding Equity Shares to Investor Education and Protection Fund (IEPF) Authority
BLISSGVS · price
▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.
Awaiting price reaction for this filing.
Bliss GVS Pharma Limited has published a notice in The Free Press Journal, Economic Times, Maharashtra Times, and Navshakti on June 30, 2025, informing shareholders about the upcoming transfer of unclaimed final dividend for FY2017-2018 and the corresponding equity shares to the IEPF Authority. This action is being taken under Section 124(6) of the Companies Act, 2013, read with the IEPF Rules, 2016, as dividends have remained unclaimed for seven or more consecutive years. Individual communications have already been sent to affected shareholders, and full details (name, folio/DP-ID, unclaimed amount, shares due) are available on the company's website. Shareholders have until September 30, 2025, to claim their dividend; otherwise, the shares will be moved to the IEPF demat account without further notice. The company's registrar for this matter is MUFG Intime India Private Limited (formerly Link Intime).
This is a routine regulatory compliance filing and is unlikely to have any direct impact on the stock price or business operations. Shareholders with unclaimed FY2017-2018 dividends must act before the September 30, 2025 deadline, or their shares will be permanently transferred to the IEPF Authority.